TMCnet News
Research and Markets: US Infectious Disease Testing Market 2014: Sales Forecasts, Supplier Shares, Competitive StrategiesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/m7xjlr/us_infectious) has announced the addition of the "US Infectious Disease Testing Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering. US Infectious Disease Testing Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends reviews current and emerging assays analyzes potential applications of innovative diagnostic technologies forecasts olume and sales for over 100 infectious disease tests by assay, and market segment provides test volume estimates by method (molecular, selorogy/immunodiagnostics, culture/microscopy) profiles leading players and potential market entrants and suggests alternative business expansion strategies for suppliers. Rationale This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies. Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is the continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections, threat of bioterrorism, advances in molecular diagnostic technologies and a wider availability of immunosuppressive drugs. Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products. For more information visit http://www.researchandmarkets.com/research/m7xjlr/us_infectious
|
